Dexcom Rival Fights Its Bid To Tweak Glucose Monitor Patent

By Jamie Lennox · February 28, 2024, 7:51 PM GMT

A Korean medical tech company has asked a London court to block Dexcom's bid to tweak its diabetes management patent to avoid losing protections should the court rule that it's invalid....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Justices' Ruling Empowers FDA To Rein In Vapes, Experts Say No Photo Available

Sam Reisman

A unanimous U.S. Supreme Court decision affirming federal regulators' authority to deny marketing applications for flavored vapes was ... (more story)

5 Fed. Circ. Clashes To Watch This Month No Photo Available

Ryan Davis

The Federal Circuit will hear arguments this month in patent cases involving Moderna's COVID-19 vaccine and a blockbuster Johnson & Jo... (more story)

Unregulated Health Cost 'Ministries' Attract State Scrutiny No Photo Available

Hannah Albarazi

Offering a cheap alternative to traditional health insurance and a faith-based approach, health cost "sharing ministries" operate acro... (more story)